miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Zhu, En Dong ^a,b   Li, Na ^a   Li, Bo Sheng ^a   Li, Wei ^a   Zhang, Wei Jun ^a   Mao, Xu Hu ^a   Guo, Gang ^a   Zou, Quan Ming ^a   Xiao, Bin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; LUCIFERASE; MICRORNA; MICRORNA 30B; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG; MIRN30 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER INHIBITION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PAI 1 GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84908327799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106049     Document Type: Article

References (49)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Bornschein J, Rokkas T, Selgrad M, Malfertheiner P (2009) Helicobacter pylori and clinical aspects of gastric cancer. Helicobacter 14 Suppl 1: 41-45.
3. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
5. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355.
6. Ebert MS, Sharp PA (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149: 515-524.
7. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America 101: 2999-3004. (Pubitemid 38327724)
8. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
9. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
10. Pencheva N, Tavazoie SF (2013) Control of metastatic progression by microRNA regulatory networks. Nature cell biology 15: 546-554.
11. Kim YK, Yu J, Han TS, Park SY, Namkoong B, et al. (2009) Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic acids research 37: 1672-1681.
12. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, et al. (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286. (Pubitemid 351318375)
13. Zhang Z, Li Z, Gao C, Chen P, Chen J, et al. (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Laboratory investigation; a - journal of technical methods and pathology 88: 1358-1366.
14. Zhao X, Dou W, He L, Liang S, Tie J, et al. (2013) MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 32: 1363-1372.
15. Xu Y, Zhao F, Wang Z, Song Y, Luo Y, et al. (2012) MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31: 1398-1407.
16. Xiao B, Liu Z, Li BS, Tang B, Li W, et al. (2009) Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. The Journal of infectious diseases 200: 916-925.
17. Liu Z, Xiao B, Tang B, Li B, Li N, et al. (2010) Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes and infection/Institut Pasteur 12: 854-863.
18. Xiao B, Zhu ED, Li N, Lu DS, Li W, et al. (2012) Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncology reports 27: 559-566.
19. Tang B, Li N, Gu J, Zhuang Y, Li Q, et al. (2012) Compromised autophagy by MIR30B benefits the intracellular survival of Helicobacter pylori. Autophagy 8:1045-1057.
20. Declerck PJ, Gils A (2013) Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin. Seminars in thrombosis and hemostasis 39:356-364.
21. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, et al. (1997) Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thrombosis and haemostasis 78: 285-296. (Pubitemid 27289256)
22. Kwaan H, Wang J, Svoboda K, Declerck P (2000) Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis. British journal of cancer 82: 1702.
23. Romer M, Due AK, Larsen JK, Hofland KF, Christensen IJ, et al. (2005) Indication of a role of plasminogen activator inhibitor type 1 in protecting murine fibrosarcoma cells against apoptosis. Thrombosis and Haemostasis 94:859.
24. Fang H, Placencio VR, DeClerck YA (2012) Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function. Journal of the National Cancer Institute 104: 1470-1484.
25. Xu T, Zhu Y, Xiong YJ, Ge YY, Yun JP, et al. (2009) MicroRNA-195 Suppresses Tumorigenicity and Regulates G 1/S Transition of Human Hepatocellular Carcinoma Cells. Hepatology 50: 113-121.
26. Chen XM, Splinter PL, O'Hara SP, LaRusso NF (2007) A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. The Journal of biological chemistry 282: 28929-28938. (Pubitemid 47610421)
27. Cotter TG (2009) Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 9: 501-507.
28. Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, et al. (2006) Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer science 97: 395-399.
29. Song JH, Meltzer SJ (2012) MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 143: 35-47 e32.
30. Li T, Lu YY, Zhao XD, Guo HQ, Liu CH, et al. (2013) MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1. Oncogene.
31. Kao CJ, Martiniez A, Shi XB, Yang J, Evans CP, et al. (2013) miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene.
32. Wszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Silva Neto B, et al. (2009) A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urologic oncology.
33. Braun J, Hoang-Vu C, Dralle H, Huttelmaier S (2010) Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene.
34. Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, et al. (2013) Differential expression of miRNAs in esophageal cancer tissue. Oncology letters 5: 1639-1642.
35. Gao W, Shen H, Liu L, Xu J, Xu J, et al. (2011) MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. Journal of cancer research and clinical oncology.
36. Lu Y, Ryan SL, Elliott DJ, Bignell GR, Futreal PA, et al. (2009) Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. PloS one 4: e6159.
37. Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, et al. (2009) CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. Genes, chromosomes & cancer 48: 615-623.
38. Huang YH, Lin KH, Chen HC, Chang ML, Hsu CW, et al. (2012) Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma. PloS one 7: e37188.
39. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, et al. (2009) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. The lancet oncology 11: 136-146.
40. Qiao F, Zhang K, Gong P, Wang L, Hu J, et al. (2014) Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis. Molecular biology reports: 1-8.
41. Xu J, Yin Z, Gao W, Liu L, Yin Y, et al. (2013) Genetic Variation in a MicroRNA-502 Minding Site in SET8 Gene Confers Clinical Outcome of Non-Small Cell Lung Cancer in a Chinese Population. PLoS ONE 8: e77024.
42. Yu F, Deng H, Yao H, Liu Q, Su F, et al. (2010) Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29:4194-4204.
43. Li J, Donath S, Li Y, Qin D, Prabhakar BS, et al. (2010) miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS genetics 6: e1000795.
44. Bridge G, Monteiro R, Henderson S, Emuss V, Lagos D, et al. (2012) The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood 120: 5063-5072.
45. Zhang J, Zhang H, Liu J, Tu X, Zang Y, et al. (2012) miR-30 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochemical and biophysical research communications 417: 1100-1105.
46. Nekarda H, Schmitt M, Ulm K, Wenninger A, Vogelsang H, et al. (1994) Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res 54: 2900-2907. (Pubitemid 24187770)
47. Ding Y, Zhang H, Zhong M, Zhou Z, Zhuang Z, et al. (2013) Clinical significance of the uPA system in gastric cancer with peritoneal metastasis. European journal of medical research 18: 28.
48. Li N, Tang B, Zhu ED, Li BS, Zhuang Y, et al. (2012) Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS letters 586: 722-728.
49. Zabaleta J (2012) MicroRNA: A Bridge from H. pylori Infection to Gastritis and Gastric Cancer Development. Frontiers in genetics 3: 294.